These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19589268)

  • 1. Characteristic genotypes of vascular endothelial growth factor are susceptible to ascites in patients with cirrhosis.
    Sohda T; Iwata K; Irie M; Takeyama Y; Nakane H; Morihara D; Kitamura Y; Yokoyama M; Shakado S; Watanabe H; Sakisaka S
    J Int Med Res; 2009; 37(3):841-6. PubMed ID: 19589268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients.
    Yang YY; Hou MC; Lin MW; Chen PH; Liao WC; Chu CJ; Lin HC
    J Gastroenterol Hepatol; 2013 Jan; 28(1):112-21. PubMed ID: 22849380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis.
    Cejudo-Martín P; Ros J; Navasa M; Fernández J; Fernández-Varo G; Ruiz-del-Arbol L; Rivera F; Arroyo V; Rodés J; Jiménez W
    Hepatology; 2001 Sep; 34(3):487-93. PubMed ID: 11526533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats.
    Melgar-Lesmes P; Tugues S; Ros J; Fernández-Varo G; Morales-Ruiz M; Rodés J; Jiménez W
    Gut; 2009 Feb; 58(2):285-92. PubMed ID: 18978178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.
    Pérez-Ruiz M; Ros J; Morales-Ruiz M; Navasa M; Colmenero J; Ruiz-del-Arbol L; Cejudo P; Clária J; Rivera F; Arroyo V; Rodés J; Jiménez W
    Hepatology; 1999 Apr; 29(4):1057-63. PubMed ID: 10094946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Negative Prognostic Impact of a First Ever Episode of Spontaneous Bacterial Peritonitis in Cirrhosis and Ascites.
    Ra G; Tsien C; Renner EL; Wong FS
    J Clin Gastroenterol; 2015; 49(10):858-65. PubMed ID: 25811112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
    Corradini SG; Morini S; Liguori F; Carotti S; Muda AO; Burza MA; Siciliano M; Molinaro A; Cantafora A; Blotta I; Merli M; Berloco P; Rossi M; Attili AF; Gaudio E
    Liver Int; 2009 Jan; 29(1):103-12. PubMed ID: 18544126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
    Lo GH; Lam HC; Cheng JT; Lin JK; Hsu JH; Lai KH; Chiang HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels.
    Seo YS; Jung ES; An H; Kim JH; Jung YK; Kim JH; Yim HJ; Yeon JE; Byun KS; Kim CD; Ryu HS; Um SH
    Liver Int; 2009 Nov; 29(10):1521-7. PubMed ID: 19725889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
    Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
    J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
    Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites.
    Rivolta R; Maggi A; Cazzaniga M; Castagnone D; Panzeri A; Solenghi D; Lorenzano E; di Palo FQ; Salerno F
    Hepatology; 1998 Nov; 28(5):1235-40. PubMed ID: 9794906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis.
    Zuckerman E; Lanir A; Sabo E; Rosenvald-Zuckerman T; Matter I; Yeshurun D; Eldar S
    Am J Gastroenterol; 1999 Jun; 94(6):1613-8. PubMed ID: 10364033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides?
    Thornton JR; Dean H; Losowsky MS
    Gut; 1988 Sep; 29(9):1167-72. PubMed ID: 3197989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma.
    Campagnolo L; Telesca C; Massimiani M; Stuhlmann H; Angelico M; Lenci I; Manzia TM; Tariciotti L; Lehmann G; Baiocchi L
    Dig Liver Dis; 2016 Jan; 48(1):76-80. PubMed ID: 26542361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat.
    Yang YY; Liu RS; Lee PC; Yeh YC; Huang YT; Lee WP; Lee KC; Hsieh YC; Lee FY; Tan TW; Lin HC
    Liver Int; 2014 Apr; 34(4):521-34. PubMed ID: 23998651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].
    Wang X; Wang BM; Jiang K; Zhang J; Fang WL; Wang T; Li XY
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):629-32. PubMed ID: 19954052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.